| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 763.45B | 773.59B | 813.42B | 781.21B | 705.66B | 595.72B |
| Gross Profit | 160.31B | 164.29B | 173.19B | 168.18B | 162.59B | 140.96B |
| EBITDA | 82.77B | 95.13B | 101.68B | 83.00B | 87.76B | 80.81B |
| Net Income | 42.22B | 45.54B | 38.82B | 49.09B | 48.30B | 36.07B |
Balance Sheet | ||||||
| Total Assets | 1.11T | 1.12T | 1.07T | 1.03T | 928.65B | 836.36B |
| Cash, Cash Equivalents and Short-Term Investments | 76.94B | 68.25B | 71.45B | 108.47B | 102.06B | 102.05B |
| Total Debt | 204.20B | 202.98B | 155.00B | 146.94B | 107.65B | 98.47B |
| Total Liabilities | 420.64B | 422.31B | 383.18B | 358.07B | 297.76B | 254.95B |
| Stockholders Equity | 663.19B | 668.22B | 657.75B | 607.61B | 568.76B | 524.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.93B | -7.34B | -7.50B | -4.26B | 17.23B |
| Operating Cash Flow | 0.00 | 75.44B | 73.47B | 55.22B | 52.09B | 55.46B |
| Investing Cash Flow | 0.00 | -90.99B | -76.17B | -64.07B | -64.95B | -40.37B |
| Financing Cash Flow | 0.00 | 4.71B | -40.69B | 8.00B | -3.67B | 5.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥408.97B | 12.16 | 9.65% | 3.91% | 0.87% | 16.71% | |
76 Outperform | ¥527.48B | 20.36 | 6.52% | 1.82% | 3.25% | -11.31% | |
74 Outperform | ¥333.84B | 12.62 | 5.47% | 3.41% | 2.60% | 9.50% | |
65 Neutral | ¥419.23B | 12.96 | 8.14% | 2.61% | -1.45% | ― | |
64 Neutral | ¥846.59B | -52.21 | -1.15% | 3.49% | -6.83% | -123.67% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥930.53B | 52.39 | 2.02% | 3.82% | -4.63% | -65.11% |
Mitsubishi Gas Chemical reported consolidated net sales of ¥549.4 billion and operating profit of ¥37.8 billion for the first nine months of FY2025, with a sharp decline in profit attributable to owners of the parent to a loss of ¥26.1 billion, mainly due to large impairment losses at its Netherlands MXDA plant and a China hydrogen peroxide facility. Despite weaker methanol and polycarbonate market prices, reduced profitability in MXDA and its derivatives, and the withdrawal from the ortho-xylene chain business, the company modestly raised its full-year operating profit forecast to ¥47.0 billion on the back of higher BT materials sales volumes, kept its full-year net sales outlook at ¥730.0 billion and maintained its dividend forecast, while flagging a gain on divestment of non-business assets to be booked in the fourth quarter.
The heavy impairments highlight ongoing portfolio restructuring and pressure in some commodity and specialty chemical segments, even as growth in BT materials and capacity expansion in inorganic chemicals signal a continued shift toward higher-value products.
The most recent analyst rating on (JP:4182) stock is a Hold with a Yen3350.00 price target. To see the full list of analyst forecasts on Mitsubishi Gas Chemical Company stock, see the JP:4182 Stock Forecast page.
Mitsubishi Gas Chemical revised its full-year consolidated forecast for the fiscal year ending March 2026, keeping net sales unchanged at ¥730 billion but raising operating profit to ¥47 billion and ordinary profit to ¥55 billion. The company now expects a deeper consolidated net loss of ¥18 billion due to impairment-related extraordinary losses, despite planned extraordinary gains from divesting non-business assets.
For the non-consolidated results, MGC maintained its net sales outlook at ¥410 billion while lifting ordinary profit to ¥38 billion and widening the projected net loss to ¥25 billion. Management cited robust demand for BT materials for IC plastic packaging and the impact of a weaker yen offsetting persistently low methanol prices, and adjusted its remaining-year exchange rate assumptions to ¥155 per U.S. dollar and ¥180 per euro, which will influence reported performance.
The most recent analyst rating on (JP:4182) stock is a Hold with a Yen3350.00 price target. To see the full list of analyst forecasts on Mitsubishi Gas Chemical Company stock, see the JP:4182 Stock Forecast page.
Mitsubishi Gas Chemical reported nine‑month consolidated net sales of ¥549.5 billion, down 5.8% year on year, with operating profit falling 16.5% to ¥37.8 billion and ordinary profit down 10.6% to ¥48.2 billion. The period swung to a loss attributable to owners of the parent of ¥26.2 billion, compared with a ¥35.6 billion profit a year earlier, and the equity ratio slipped to 57.2% from 59.7%.
Despite weaker earnings and a projected full‑year net loss of ¥18.0 billion for the fiscal year ending March 31, 2026, the company plans to raise total annual dividends to ¥100 per share from ¥95 in the previous year. Management revised its full‑year forecast lower, now expecting declines in net sales, operating profit, and ordinary profit, signaling ongoing earnings pressure even as shareholder returns are maintained.
The most recent analyst rating on (JP:4182) stock is a Hold with a Yen3350.00 price target. To see the full list of analyst forecasts on Mitsubishi Gas Chemical Company stock, see the JP:4182 Stock Forecast page.